GlassScriptPhysician profile
Ramin M Roohipour
NPI 1275768467
$3,300.65
in general payments reported to CMS, 2019-2025
10 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $54.13 · 2021: $174 · 2022: $1,153 · 2023: $625 · 2024: $372 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,514.84 | 2021-2025 | Signia, Sonicision, Ligasure |
| Covidien LP | $226.47 | 2019-2020 | |
| Intuitive Surgical, INC. | $169.05 | 2022 | |
| Mallinckrodt Enterprises LLC | $120.57 | 2019 | |
| Tela Bio, INC. | $89.97 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $51.46 | 2025 | |
| Apollo Endosurgery US INC | $43.40 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Laborie Medical Technologies Corp. | $32.43 | 2024 | Alphaone |
| Boston Scientific Corporation | $30.15 | 2023 | |
| Integra Lifesciences Corporation | $22.31 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramin Roohipour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.